The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Adverse events in real-world patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) who received FOLFIRINOX (FFX) or gemcitabine with nab-paclitaxel (GnP) in the first line (1L).

Syvart  Dennen

Research Funding - Ipsen (Inst)

Michelle  Silver

No Relationships to Disclose

Paul  Cockrum

Employment - Ipsen

Stock and Other Ownership Interests  - Ipsen

Research Funding - Ipsen (Inst)

Ravi Kumar  Paluri

Honoraria - Exelixis; Ipsen; Seagen

Consulting or Advisory Role - Exelixis; Ipsen

Speakers' Bureau - Exelixis; Ipsen

Research Funding - Geistlich Pharma; Minneamrita Therapeutics; Seagen